Commenters on the US Food and Drug Administration’s (FDA) draft guidance outlining principles for in vivo or in vitro bioequivalence studies (BE) for investigational new drugs (INDs), new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results